Generic for Popular Asthma Inhaler Gets FDA OK
By Robert Preidt HealthDay Reporter THURSDAY, Jan. 31, 2019 (HealthDay News) — The first generic version of the widely used Advair Diskus inhaler for asthma and chronic obstructive pulmonary disease (COPD) has won U.S. Food and Drug Administration approval. This approval “is part of our longstanding commitment to advance access to lower cost, high-quality generic… Read More »